Malignant Pharyngeal Neoplasm — Trials

Malignant Pharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,255 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 222
Ph III recruiting: 64
Growth YoY: +6.1%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03618654	Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma	completed	Early Phase 1	38	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	May 15, 2025	clinicaltrials
NCT00140556	Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer	completed	Early Phase 1	28	David M. Brizel, MDOTHER	1	Jan 18, 2013